EXUMA Biotech logo

EXUMA Biotech

25 employees · est. 2015 · West Palm Beach, United Stat...

VS
Neukio Biotherapeutics logo

Neukio Biotherapeutics

Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis.

14 employees · est. 2021 · China

EXUMA Biotech is the older company (2015 vs 2021).

Side-by-Side Comparison

EXUMA Biotech Neukio Biotherapeutics
Founded
2015 older 2021
Headquarters
West Palm Beach, United States China
Employees
25 14
Industry
Big Data, Biotechnology, Health Care Biotechnology
Funding Stage
Series B Series A
Total Funding
$107.00M $90.00M
Funding Rounds
4 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immuno-Oncology, CAR-T, Cell Therapy, Gene Therapy, Viral Engineering, CAR-NK, Oncology, Immunotherapy Cell Therapy, Allogenic, IPSC, CAR-NK, Immuno-oncology, Innovation, Oncology, Immune System, Therapy Development, Biotherapeutics
Website
exumabio.com neukio.com
EXUMA Biotech logo

About EXUMA Biotech

EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, the company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman...

Neukio Biotherapeutics logo

About Neukio Biotherapeutics

Neukio Biotherapeutics is a China-based biotechnology startup that was founded in 2021. The company focuses on the development of next-generation allogenic cell therapies via the iPSC-CAR-NK axis, emphasizing innovative immuno-oncology products. Recently, on 02 September 2022, Neukio Biotherapeutics...

We will tell you when either one moves

BounceWatch watches EXUMA Biotech and Neukio Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EXUMA Biotech and Neukio Biotherapeutics — by email.

Frequently Asked Questions

EXUMA Biotech. Neukio Biotherapeutics — Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EXUMA Biotech has raised $107.00M while Neukio Biotherapeutics has raised $90.00M.
EXUMA Biotech and Neukio Biotherapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EXUMA Biotech with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at EXUMA Biotech on 11 Sep 2024, and Neukio Biotherapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes